British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development center in the Chinese capital.

BEIJING] AstraZeneca will invest US$2.5 billion in a new research centre in Beijing, in a major show of commitment to China just months after the company’s top executive there was detained by authorities.

AstraZeneca Plc will invest $2.5 billion in a new research center in Beijing, in a major show of commitment to China just months after the company’s top executive there was detained by authorities. Most Read from BloombergNew York Subway Ditches MetroCard After 32 Years for Tap-And-GoDespite Cost-Cutting Moves,